Our Partner and Head of Life Sciences & Healthcare Irene Kyriakides, along with her team, recently contributed to the latest ICLG Pharmaceutical Advertising 2025 Guide, offering a clear roadmap through one of the most regulated sectors in Greece.

In the chapter on Pharmaceutical Advertising Laws & Regulations – Greece, they break down the latest legal framework and compliance requirements, including:

◼️ Key Legislation, Guidance & Industry Codes: A comprehensive overview of the national laws, EU regulations, authorities’ guidelines and industry codes (SFEE, EFPIA) governing promotional activities for prescription and OTC medicines.
◼️ What Constitutes “Advertising”: From public campaigns to social media—understand what qualifies as advertising.
◼️ Internal Company Compliance: Why having a qualified Scientific Committee and clear SOPs is not just best practice—but essential.
◼️ Authority’s Assessment: What EOF requires when it comes to promotional materials, including vaccination campaigns submissions.
◼️ Enforcement Trends: What happens when things go wrong—and who can file complaints (spoiler: it’s not just regulators).
◼️ Promoting Future or Off-label Products: Clear rules on what’s allowed pre-authorisation—and how far scientific exchange can go without crossing into advertising.
◼️ Collaboration with HCPs & HCOs: Boundaries around gifts, hospitality, advisory boards and grants, with strict financial and procedural limitations.

The takeaway? Compliance is non-negotiable—but with the right guidance, pharmaceutical companies can promote their products lawfully and effectively in Greece.